Breast Cancer Detection from sample to result in one day!
Orion Diagnostica is pleased to present the new product MammaTyper® from BioNTech Diagnostics GmbH. MammaTyper® is an in vitro diagnostic test that provides information of the four breast cancer biomarkers recommended by the St Gallen expert panel(1). The test is also intended for molecular subtyping as well as it can be used as a prognostic tool for patient’s risk of developing distant metastases and overall survival.
MammaTyper® has proven a very high performance compared with IHC(2) and can be used in any molecular pathology laboratory with same-day results!
MAMMATYPER is a registered trademark of BIONTECH DIAGNOSTICS GmbH
Read more about the test: www.mammatyper.com
1. Goldhirsch et al. Annals of Oncology. 2013; Sep; 24(9): 2206-2223
2. Wirtz et al. Breast Cancer Res Treat. 2016; 157: 437–446